| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 53,822 | $2,043,621 | $37.97 | 16 Feb 2023 | Direct |
| BridgeBio Pharma, Inc. | Director | Restricted Stock Units | 12,783 | $377,738 | $29.55 | 16 Feb 2023 | Direct |
| Oric Pharmaceuticals, Inc. | Director | Common Stock | 39,092 | $335,640 | $8.59 | 24 May 2021 | Direct |
| 23andMe Holding Co. | Director | Class A Common Stock | 895,961 | $299,341 | $0.3341 | 26 Aug 2024 | Direct |
| Alector, Inc. | Director | Common Stock | 95,366 | $110,624 | $1.16 | 11 Jun 2025 | Direct |
| Maze Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $22.37 | 15 Sep 2025 | Direct |
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18,000 | 22 Sep 2025 | Direct | ||
| Alector, Inc. | Director | Stock Option (right to buy) | 9,450 | 11 Jun 2025 | Direct | ||
| DICE Therapeutics, Inc. | Director | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Director | 24 Sep 2025, 16:18 |
| MAZE | Maze Therapeutics, Inc. | 15 Sep 2025 | 1 | -$464,035 | 4 | Director | 16 Sep 2025, 16:26 |
| ALEC | Alector, Inc. | 11 Jun 2025 | 2 | $0 | 4 | Director | 12 Jun 2025, 18:05 |
| ALEC | Alector, Inc. | 02 May 2025 | 1 | $0 | 4 | Director | 02 May 2025, 18:00 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:35 |
| ME | 23andMe Holding Co. | 26 Aug 2024 | 1 | $0 | 4 | Director | 28 Aug 2024, 16:34 |
| ALEC | Alector, Inc. | 22 Aug 2024 | 1 | -$228,388 | 4 | Director | 23 Aug 2024, 16:05 |
| ALEC | Alector, Inc. | 02 Aug 2024 | 1 | $0 | 4 | Director | 10 Oct 2024, 16:05 |
| ALEC | Alector, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 12 Jun 2024, 16:46 |
| ME | 23andMe Holding Co. | 06 Sep 2023 | 1 | $0 | 4 | Director | 08 Sep 2023, 16:57 |
| DICE | DICE Therapeutics, Inc. | 09 Aug 2023 | 6 | $0 | 4 | Director | 09 Aug 2023, 16:29 |
| ALEC | Alector, Inc. | 15 Jul 2023 | 1 | $0 | 4 | Director | 14 Feb 2024, 17:58 |
| ALEC | Alector, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 15 Jun 2023, 16:02 |
| DICE | DICE Therapeutics, Inc. | 05 May 2023 | 1 | -$3,238,205 | 4 | Director | 09 May 2023, 18:02 |
| BBIO | BridgeBio Pharma, Inc. | 16 Feb 2023 | 3 | -$16,483 | 4 | Director | 21 Feb 2023, 19:21 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2022 | 3 | -$10,662 | 4 | Director | 18 Nov 2022, 17:38 |
| ME | 23andMe Holding Co. | 11 Nov 2022 | 1 | -$59,684 | 4 | Director | 14 Nov 2022, 15:38 |
| ME | 23andMe Holding Co. | 06 Sep 2022 | 1 | $0 | 4 | Director | 08 Sep 2022, 16:47 |
| ME | 23andMe Holding Co. | 25 Aug 2022 | 1 | $0 | 4 | Director | 29 Aug 2022, 16:29 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2022 | 3 | -$12,199 | 4 | Director | 18 Aug 2022, 18:35 |
| BBIO | BridgeBio Pharma, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:36 |
| ALEC | Alector, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 20:06 |
| DICE | DICE Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 16:48 |
| BBIO | BridgeBio Pharma, Inc. | 16 May 2022 | 3 | -$8,829 | 4 | Director | 18 May 2022, 16:09 |
| BBIO | BridgeBio Pharma, Inc. | 28 Feb 2022 | 1 | $0 | 4 | Director | 15 Mar 2022, 17:37 |
| BBIO | BridgeBio Pharma, Inc. | 02 Dec 2021 | 2 | $0 | 4 | Director | 06 Dec 2021, 19:55 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 6 | $0 | 4 | Director | 16 Sep 2021, 21:26 |
| ME | 23andMe Holding Co. | 14 Sep 2021 | 1 | $0 | 4 | Director | 16 Sep 2021, 16:24 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 0 | $0 | 3 | Director | 14 Sep 2021, 19:23 |
| BBIO | BridgeBio Pharma, Inc. | 04 Aug 2021 | 3 | -$499,108 | 4 | Title: Chairman of Research and Development, Director | 06 Aug 2021, 18:08 |
| ALEC | Alector, Inc. | 02 Jul 2021 | 5 | -$1,297,673 | 4 | Director | 09 Aug 2021, 18:13 |
| BBIO | BridgeBio Pharma, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Chairman of R&D, Director | 22 Jun 2021, 18:51 |
| ALEC | Alector, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:05 |
| ME | 23andMe Holding Co. | 16 Jun 2021 | 0 | $0 | 3 | Director | 25 Jun 2021, 17:24 |
| ORIC | Oric Pharmaceuticals, Inc. | 20 May 2021 | 3 | -$50,036 | 4 | Director | 24 May 2021, 19:29 |
| ORIC | Oric Pharmaceuticals, Inc. | 14 May 2021 | 3 | -$200,605 | 4 | Director | 18 May 2021, 20:20 |
| ORIC | Oric Pharmaceuticals, Inc. | 11 May 2021 | 3 | -$12,623 | 4 | Director | 13 May 2021, 19:59 |